404 related articles for article (PubMed ID: 21324934)
1. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients.
Maron BJ; Yacoub M; Dearani JA
Eur Heart J; 2011 May; 32(9):1055-8. PubMed ID: 21324934
[TBL] [Abstract][Full Text] [Related]
2. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
3. Does myectomy convey survival benefit in hypertrophic cardiomyopathy?
Woo A; Rakowski H
Heart Fail Clin; 2007 Jul; 3(3):275-88. PubMed ID: 17723936
[TBL] [Abstract][Full Text] [Related]
4. The case for surgery in obstructive hypertrophic cardiomyopathy.
Maron BJ; Dearani JA; Ommen SR; Maron MS; Schaff HV; Gersh BJ; Nishimura RA
J Am Coll Cardiol; 2004 Nov; 44(10):2044-53. PubMed ID: 15542290
[TBL] [Abstract][Full Text] [Related]
5. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?
Olivotto I; Ommen SR; Maron MS; Cecchi F; Maron BJ
J Am Coll Cardiol; 2007 Aug; 50(9):831-4. PubMed ID: 17719467
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
Ommen SR; Maron BJ; Olivotto I; Maron MS; Cecchi F; Betocchi S; Gersh BJ; Ackerman MJ; McCully RB; Dearani JA; Schaff HV; Danielson GK; Tajik AJ; Nishimura RA
J Am Coll Cardiol; 2005 Aug; 46(3):470-6. PubMed ID: 16053960
[TBL] [Abstract][Full Text] [Related]
7. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
Noble S; Sigwart U
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
[TBL] [Abstract][Full Text] [Related]
9. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
Veselka J
Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
[TBL] [Abstract][Full Text] [Related]
10. Surgery insight: Septal myectomy for obstructive hypertrophic cardiomyopathy--the Mayo Clinic experience.
Dearani JA; Ommen SR; Gersh BJ; Schaff HV; Danielson GK
Nat Clin Pract Cardiovasc Med; 2007 Sep; 4(9):503-12. PubMed ID: 17712363
[TBL] [Abstract][Full Text] [Related]
11. Septal myectomy for obstructive hypertrophic cardiomyopathy.
Dearani JA; Danielson GK
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2005; ():86-91. PubMed ID: 15818363
[TBL] [Abstract][Full Text] [Related]
12. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
[TBL] [Abstract][Full Text] [Related]
13. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
[TBL] [Abstract][Full Text] [Related]
14. New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard?
Hess OM; Sigwart U
J Am Coll Cardiol; 2004 Nov; 44(10):2054-5. PubMed ID: 15542291
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy.
Minakata K; Dearani JA; Schaff HV; O'Leary PW; Ommen SR; Danielson GK
Ann Thorac Surg; 2005 Sep; 80(3):851-6. PubMed ID: 16122442
[TBL] [Abstract][Full Text] [Related]
16. [Septal myectomy for obstructive hypertrophic cardiomyopathy: the gold standard].
Dearani JA; Schaff HV; Ommen SR
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Apr; 37(4):307-11. PubMed ID: 19791464
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy.
Sedehi D; Finocchiaro G; Tibayan Y; Chi J; Pavlovic A; Kim YM; Tibayan FA; Reitz BA; Robbins RC; Woo J; Ha R; Lee DP; Ashley EA
J Cardiol; 2015 Jul; 66(1):57-62. PubMed ID: 25238885
[TBL] [Abstract][Full Text] [Related]
18. Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation.
Lever HM
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():27-30. PubMed ID: 17162266
[TBL] [Abstract][Full Text] [Related]
19. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.
Ferrazzi P; Spirito P; Iacovoni A; Calabrese A; Migliorati K; Simon C; Pentiricci S; Poggio D; Grillo M; Amigoni P; Iascone M; Mortara A; Maron BJ; Senni M; Bruzzi P
J Am Coll Cardiol; 2015 Oct; 66(15):1687-96. PubMed ID: 26449139
[TBL] [Abstract][Full Text] [Related]
20. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
